| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |